• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-018
Device Problem Insufficient Information (3190)
Patient Problems Erosion (1750); Chest Pain (1776); Cardiac Perforation (2513)
Event Date 11/22/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
In (b)(6) 2010, a 19 mm amplatzer septal occluder (aso) was deployed in this pediatric patient.Per report, the atrial septal defect had no aortic rim and measured 14 mm x 11 mm.The defect was balloon-sized to 17.5-18.7 mm.Per report, there were two smaller defects 3 mm in size near the central defect.The posterior rim measured over 5 mm.However, the 19 mm aso¿s discs reportedly compressed against the aortic root so the 19 mm aso was removed still attached to the delivery cable.Next, a 17 mm aso was attempted; however, during the wiggle test the rims prevented the aso from being placed so the 17 mm aso was removed still attached to the delivery cable.An 18 mm aso was selected and implanted without issue.On (b)(6) 2016, the patient experienced chest pain and was admitted.On (b)(6) 2016, a transthoracic echo (tte) revealed a 2.5 mm pericardial effusion and 250 ml of blood was removed via pericardiocentesis and the patient was urgently transferred to another hospital at which time the aso was surgically removed and the atrial septal defect was repaired using a patch.Prior to explant, the tte revealed abnormal flow around the transverse sinus on the aorta side of the disks.Per report, the left atrial roof was suspected to have eroded; however, the actual erosion site was located at the inner surface of the left disc, not the device edge.On (b)(6) 2016, the patient was discharged from the hospital in stable condition.
 
Manufacturer Narrative
(b)(4).The results of the investigation are inconclusive since the device was not returned for analysis.A review of the device history record was not possible since the serial number was unavailable.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
This event was reviewed by the st.Jude medical erosion board and confirmed that erosion occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6187249
MDR Text Key62798931
Report Number2135147-2016-00128
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-018
Device Catalogue Number9-ASD-018
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age14 YR
-
-